These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Nab-paclitaxel for breast cancer: a new formulation with an improved safety profile and greater efficacy. Henderson IC; Bhatia V Expert Rev Anticancer Ther; 2007 Jul; 7(7):919-43. PubMed ID: 17627452 [TBL] [Abstract][Full Text] [Related]
7. Phase II study of weekly albumin-bound paclitaxel for patients with metastatic breast cancer heavily pretreated with taxanes. Blum JL; Savin MA; Edelman G; Pippen JE; Robert NJ; Geister BV; Kirby RL; Clawson A; O'Shaughnessy JA Clin Breast Cancer; 2007 Dec; 7(11):850-6. PubMed ID: 18269774 [TBL] [Abstract][Full Text] [Related]
8. Targeted delivery for breast cancer therapy: the history of nanoparticle-albumin-bound paclitaxel. Petrelli F; Borgonovo K; Barni S Expert Opin Pharmacother; 2010 Jun; 11(8):1413-32. PubMed ID: 20446855 [TBL] [Abstract][Full Text] [Related]
9. nab-paclitaxel: a novel formulation of taxane for treatment of breast cancer. Vishnu P; Roy V Womens Health (Lond); 2010 Jul; 6(4):495-506. PubMed ID: 20597612 [TBL] [Abstract][Full Text] [Related]
10. Multicenter phase II trial of ABI-007, an albumin-bound paclitaxel, in women with metastatic breast cancer. Ibrahim NK; Samuels B; Page R; Doval D; Patel KM; Rao SC; Nair MK; Bhar P; Desai N; Hortobagyi GN J Clin Oncol; 2005 Sep; 23(25):6019-26. PubMed ID: 16135470 [TBL] [Abstract][Full Text] [Related]
11. Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. Desai N; Trieu V; Yao Z; Louie L; Ci S; Yang A; Tao C; De T; Beals B; Dykes D; Noker P; Yao R; Labao E; Hawkins M; Soon-Shiong P Clin Cancer Res; 2006 Feb; 12(4):1317-24. PubMed ID: 16489089 [TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy evaluation of albumin-bound paclitaxel. Cecco S; Aliberti M; Baldo P; Giacomin E; Leone R Expert Opin Drug Saf; 2014 Apr; 13(4):511-20. PubMed ID: 24559090 [TBL] [Abstract][Full Text] [Related]
13. The role of albumin-bound paclitaxel in metastatic breast cancer. Russell C Clin Adv Hematol Oncol; 2011 Jun; 9(6):469-71. PubMed ID: 21841747 [No Abstract] [Full Text] [Related]
14. Comparative preclinical and clinical pharmacokinetics of a cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in Cremophor (Taxol). Sparreboom A; Scripture CD; Trieu V; Williams PJ; De T; Yang A; Beals B; Figg WD; Hawkins M; Desai N Clin Cancer Res; 2005 Jun; 11(11):4136-43. PubMed ID: 15930349 [TBL] [Abstract][Full Text] [Related]
15. Enhancing intracellular taxane delivery: current role and perspectives of nanoparticle albumin-bound paclitaxel in the treatment of advanced breast cancer. Guarneri V; Dieci MV; Conte P Expert Opin Pharmacother; 2012 Feb; 13(3):395-406. PubMed ID: 22263900 [TBL] [Abstract][Full Text] [Related]
16. Nab-paclitaxel in the treatment of metastatic breast cancer: a comprehensive review. Montero AJ; Adams B; Diaz-Montero CM; Glück S Expert Rev Clin Pharmacol; 2011 May; 4(3):329-34. PubMed ID: 22114779 [TBL] [Abstract][Full Text] [Related]
17. First line treatment of advanced non-small-cell lung cancer - specific focus on albumin bound paclitaxel. Gupta N; Hatoum H; Dy GK Int J Nanomedicine; 2014; 9():209-21. PubMed ID: 24399877 [TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of taxane-trastuzumab combination regimens for HER-2-positive metastatic breast cancer. Bullock K; Blackwell K Oncologist; 2008 May; 13(5):515-25. PubMed ID: 18515736 [TBL] [Abstract][Full Text] [Related]
19. Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL-free formulation of paclitaxel. Stinchcombe TE Nanomedicine (Lond); 2007 Aug; 2(4):415-23. PubMed ID: 17716129 [TBL] [Abstract][Full Text] [Related]
20. Albumin-bound paclitaxel: the benefit of this new formulation in the treatment of various cancers. Montana M; Ducros C; Verhaeghe P; Terme T; Vanelle P; Rathelot P J Chemother; 2011 Apr; 23(2):59-66. PubMed ID: 21571619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]